Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Phase I Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART

NCT01571466 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT01571466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01571466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Phase I Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
Lead sponsor
Hospital Clinic of Barcelona
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2011
Completion date
May 31, 2013
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection